Katase, N., Nishimatsu, S., Yamauchi, A., Okano, S., & Fujita, S. (2022). Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC). Cancer Cell International, 22(1), 1. https://doi.org/10.1186/s12935-022-02783-9
Chicago Style (17th ed.) CitationKatase, Naoki, Shin-ichiro Nishimatsu, Akira Yamauchi, Shinji Okano, and Shuichi Fujita. "Establishment of Anti-DKK3 Peptide for the Cancer Control in Head and Neck Squamous Cell Carcinoma (HNSCC)." Cancer Cell International 22, no. 1 (2022): 1. https://doi.org/10.1186/s12935-022-02783-9.
MLA (9th ed.) CitationKatase, Naoki, et al. "Establishment of Anti-DKK3 Peptide for the Cancer Control in Head and Neck Squamous Cell Carcinoma (HNSCC)." Cancer Cell International, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12935-022-02783-9.